Methyl-donor supplementation in obese mice prevents the progression of NAFLD, activates AMPK and decreases acyl-carnitine levels
Christoph Dahlhoff(Weihenstephan-Triesdorf University of Applied Sciences), Hannelore Daniel(Technical University of Munich), Stefanie Worsch(Technical University of Munich), Jürgen Geisel(Saarland University), Kirsten Uebel(Technical University of Munich), Manuela Sailer(Technical University of Munich), Björn Hummel(Saarland University), Rima Obeid(Saarland University), B. Bader(Technical University of Munich), Christian Scherling(Technical University of Munich), Jarlei Fiamoncini(Universidade de São Paulo)
Cited by 113
Related Papers
Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia
|FEBS Letters|2006|488
Homocysteine and Dementia: An International Consensus Statement
|Journal of Alzheimer s Disease|2018|360
The Metabolic Burden of Methyl Donor Deficiency with Focus on the Betaine Homocysteine Methyltransferase Pathway
|Nutrients|2013|282
Vitamin B-12 status, particularly holotranscobalamin II and methylmalonic acid concentrations, and hyperhomocysteinemia in vegetarians
|American Journal of Clinical Nutrition|2003|252
Nutrimetabolomics: An Integrative Action for Metabolomic Analyses in Human Nutritional Studies
|Molecular Nutrition & Food Research|2018|238